go back

Brexucabtagene Autoleucel (Tecartus) CAR-T Therapy

Nevada rates for HCPCS Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $489,779 · 10th–90th $416,869$1,230,2690%20%40%10th90th$489,779Professionalmedian $489,779 · 10th–90th $489,779$562,3410%50%90th$489,779$0.1$1.0$20.0$500.0$10.0K$200.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$489,778.82
Median
$776,247.12
Typical High
$2,089,296.13
Aetna
Setting
Professional
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$537,031.80
Anthem BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.03
Median
$0.03
Typical High
$0.03
Anthem BCBS
Setting
Professional
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$489,778.82
Cigna
Setting
Professional
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$588,843.66
Hometown Health
Setting
Professional
Modifier
Global
Typical Low
$512,861.38
Median
$512,861.38
Typical High
$602,559.59
Select Health
Setting
Facility
Modifier
Global
Typical Low
$416,869.38
Median
$436,515.83
Typical High
$489,778.82
Select Health
Setting
Professional
Modifier
Global
Typical Low
$436,515.83
Median
$489,778.82
Typical High
$512,861.38
United
Setting
Professional
Modifier
Global
Typical Low
$457,088.19
Median
$549,540.87
Typical High
$758,577.58